title: Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
authors.affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
authors.forename: Kohtaro
authors.initials: K
authors.lastname: Ooka
authors.affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
authors.forename: James J
authors.initials: JJ
authors.lastname: Connolly
authors.affiliation: Yale Liver Center, Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Lim
mesh_terms: D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics; D008484:Medicaid / Q000191:economics*; D000069474:Sofosbuvir / Q000008:administration & dosage / Q000191:economics; D014481:United States
chemical_list: D000998:Antiviral Agents; D000069474:Sofosbuvir